Elevated Lp(a) levels associated with residual cardiovascular risk
Summary
New data analyzing more than 20,000 patients from three major NIH studies show that elevated Lipoprotein(a) [Lp(a)] is associated with residual cardiovascular risk and warrants aggressive risk reduction.
Description
New data analyzing more than 20,000 patients from three major NIH studies show that elevated Lipoprotein(a) [Lp(a)] is associated with residual cardiovascular risk and warrants aggressive risk reduction.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source